La SOD Clinica di Dermatologia è costantemente impegnata in attività di ricerca scientifica come testimoniato dai lavori pubblicati su riviste internazionali e nazionali sotto-riportati. Per semplificare alleghiamo elenco dei lavori scientifici del biennio 2014-2015 :
1) BIOLOGIC THERAPY IN IMMUNE MEDIATED INFLAMMATORY DISEASE: BASIC SCIENCE AND CLINICAL CONCEPTS., Molinelli E, Campanati A, Ganzetti G, Offidani A., Curr Drug Saf. 2015 Oct 14.
2) BIOLOGIC THERAPY IN PSORIASIS: SAFETY PROFILE., Campanati A, Ganzetti G, Giuliodori K, Molinelli E, Offidani A., Curr Drug Saf. 2015 Oct 14.
3) BIOLOGIC THERAPY IN INFLAMMATORY AND IMMUNOMEDIATED SKIN DISEASES: SAFETY PROFILE., Ganzetti G, Campanati A, Molinelli E, Offidani A., Curr Drug Saf. 2015 Oct 14.
4) Coexistence of systemic lupus erythematosus, Hashimoto's thyroiditis, and bilateral breast cancer in the same patient: a random association?, Molinelli E, Giuliodori K, Campanati A, Brisigotti V, Offidani A., Acta Dermatovenerol Alp Pannonica Adriat. 2015 Sep;24(3):55-7.
5) Pseudoxanthoma elasticum and skin: Clinical manifestations, histopathology, pathomechanism, perspectives of treatment., Marconi B, Bobyr I, Campanati A, Molinelli E, Consales V, Brisigotti V, Scarpelli M, Racchini S,Offidani A., Intractable Rare Dis Res. 2015 Aug;4(3):113-22. doi: 10.5582/irdr.2015.01014.
6) Active inflammatory biomarkers in oral lichen planus., Santarelli A, Mascitti M, Rubini C, Zizzi A, Offidani A, Ganzetti G, Laino L, Cicciù M, Muzio LL., Int J Immunopathol Pharmacol. 2015 Aug 24. pii: 0394632015592101
7) The transitioning from conventional therapy to biological treatment in psoriatic patients: STRATOS, a regional Marche project., Ganzetti G, Campanati A, Bernardini ML, Bettacchi A, Brandozzi G, Brisigotti V, Cataldi I, Filosa G, Giacchetti A, Lemme G, Morresi L, Nicolini M, Postacchini V, Ricotti G, Rosa L, Simonacci M,Offidani A., G Ital Dermatol Venereol. 2015 Jun 19.
8) Osteopontin: a new facilitating factor in alopecia areata pathogenesis?, Ganzetti G, Simonetti O, Campanati A, Giuliodori K, Scocco V, Brugia M, Tocchini M, Offidani A., Acta Dermatovenerol Croat. 2015;23(1):19-22.
9) Serum levels of adipocytokines in psoriasis patients receiving tumor necrosis factor-α inhibitors: results of a retrospective analysis., Campanati A, Ganzetti G, Giuliodori K, Marra M, Bonfigli A, Testa R, Offidani A., Int J Dermatol. 2015 Jul;54(7):839-45. doi: 10.1111/ijd.12706.
10) Clinical and prognostic significance of survivin, AKT and VEGF in primary mucosal oral melanoma., Simonetti O, Lucarini G, Rubini C, Lazzarini R, DI Primio R, Offidani A., Anticancer Res. 2015 Apr;35(4):2113-20.
11) Non-alcoholic fatty liver disease and psoriasis: So far, so near., Ganzetti G, Campanati A, Offidani A., World J Hepatol. 2015 Mar 27;7(3):315-26. doi: 10.4254/wjh.v7.i3.315.
12) Cutaneous vasculitis and inflammatory bowel diseases., Simonetti O, Postacchini V, Offidani A., G Ital Dermatol Venereol. 2015 Apr;150(2):233-6. Epub 2015 Mar 31.
13) Skin features in myotonic dystrophy type 1: an observational study., Campanati A, Giannoni M, Buratti L, Cagnetti C, Giuliodori K, Ganzetti G, Silvestrini M, Provinciali L,Offidani A., Neuromuscul Disord. 2015 May;25(5):409-13. doi: 10.1016/j.nmd.2015.02.013.
14) Homocysteine plasma levels in psoriasis patients: our experience and review of the literature., Giannoni M, Consales V, Campanati A, Ganzetti G, Giuliodori K, Postacchini V, Liberati G, Azzaretto L, Vichi S, Guanciarossa F, Offidani A., J Eur Acad Dermatol Venereol. 2015 Sep;29(9):1781-5. doi: 10.1111/jdv.13023.
15) Helicobacter pylori infection in psoriasis: results of a clinical study and review of the literature., Campanati A, Ganzetti G, Martina E, Giannoni M, Gesuita R, Bendia E, Giuliodori K, Sandroni L,Offidani A., Int J Dermatol. 2015 May;54(5):e109-14. doi: 10.1111/ijd.12798.
16) IL-17, IL-23, and p73 expression in cutaneous melanoma: a pilot study., Ganzetti G, Rubini C, Campanati A, Zizzi A, Molinelli E, Rosa L, Simonacci F, Offidani A., Melanoma Res. 2015 Jun;25(3):232-8. doi: 10.1097/CMR.0000000000000151.
17) Kaposi-Juliusberg varicelliform eruption in patient suffering from Darier-White disease: a case report and review of the literature., Molinelli E, Ricotti F, Campanati A, Cataldi I, Ganzetti G, Liberati G, Bianchelli T, Offidani A., G Ital Dermatol Venereol. 2014 Dec 11
18) Latent tuberculosis infection in patients with chronic plaque psoriasis: evidence from the Italian Psocare Registry., Gisondi P, Cazzaniga S, Chimenti S, Maccarone M, Picardo M, Girolomoni G, Naldi L; Psocare Study Group., Br J Dermatol. 2015 Jun;172(6):1613-20. doi: 10.1111/bjd.13539.
19) Use of infliximab in toxic epidermal necrolysis: a still opened challenge., Ganzetti G, Campanati A, Simonetti O, Giuliodori K, Giangiacomi M, Lemme G, Offidani A., G Ital Dermatol Venereol. 2015 Aug;150(4):467-71.
20) Hidradenoma papilliferum, diagnostic challenge: a case., Campanati A, Giuliodori K, Ganzetti G, Liberati G, Cellini A, Giangiacomi M, Marconi B, Lemme G,Offidani A., G Ital Dermatol Venereol. 2014 Nov 12.
21) Periodontal disease: an oral manifestation of psoriasis or an occasional finding?, Ganzetti G, Campanati A, Santarelli A, Pozzi V, Molinelli E, Minnetti I, Brisigotti V, Procaccini M, Emanuelli M, Offidani A., Drug Dev Res. 2014 Nov;75 Suppl 1:S46-9. doi: 10.1002/ddr.21194.
22) Finally, recurrent pyoderma gangrenosum treated with Adalimumab: case report and review of the literature., Campanati A, Brisigotti V, Ganzetti G, Molinelli E, Giuliodori K, Consales V, Racchini S, Bendia E,Offidani A., J Eur Acad Dermatol Venereol. 2015 Jun;29(6):1245-7. doi: 10.1111/jdv.12703.
23) Characterization and profiling of immunomodulatory genes in resident mesenchymal stem cells reflect the Th1-Th17/Th2 imbalance of psoriasis., Campanati A, Orciani M, Consales V, Lazzarini R, Ganzetti G, Di Benedetto G, Di Primio R, Offidani A., Arch Dermatol Res. 2014 Dec;306(10):915-20. doi: 10.1007/s00403-014-1493-3.
24) Involvement of the oral cavity in psoriasis: results of a clinical study., Ganzetti G, Campanati A, Santarelli A, Pozzi V, Molinelli E, Minnetti I, Brisigotti V, Procaccini M, Emanuelli M, Offidani A., Br J Dermatol. 2015 Jan;172(1):282-5. doi: 10.1111/bjd.13201
25) Elastosis perforans serpiginosa: a case successfully treated with intralesional steroids and topical allium cepa-allantoin-pentaglycan gel., Campanati A, Martina E, Giuliodori K, Ganzetti G, Marconi B, Conta I, Giangiacomi M, Offidani A., Acta Dermatovenerol Alp Pannonica Adriat. 2014;23(2):39-41.
26) Rosacea: could topical azelaic acid and oral tetracyclines modify videocapillaroscopic pattern?, Ganzetti G, Giuliodori K, Campanati A, Offidani A., Skinmed. 2014 Mar-Apr;12(2):128-30.
27) Electrochemotherapy: an effective local treatment of cutaneous and subcutaneous melanoma metastases., Ricotti F, Giuliodori K, Cataldi I, Campanati A, Ganzetti G, Ricotti G, Offidani A., Dermatol Ther. 2014 May-Jun;27(3):148-52. doi: 10.1111/dth.12098.
28) Atopic myelitis is not restricted to Japanese patients., Buratti L, Cagnetti C, Campanati A, Logullo F, Offidani A, Provinciali L., Neurol Sci. 2014 Nov;35(11):1835-7. doi: 10.1007/s10072-014-1832-3
29) Psoriasis beyond the skin surface: a pilot study on the ocular involvement., Campanati A, Neri P, Giuliodori K, Arapi I, Carbonari G, Borioni E, Herbort CP, Mariotti C, Giovannini A, Offidani A., Int Ophthalmol. 2015 Jun;35(3):331-40. doi: 10.1007/s10792-014-9950-8.
30) The potential effect of the tumour necrosis factor-α inhibitors on vitamin D status in psoriatic patients., Ganzetti G, Campanati A, Scocco V, Brugia M, Tocchini M, Liberati G, Giuliodori K, Brisigotti V,Offidani A., Acta Derm Venereol. 2014 Nov;94(6):715-7. doi: 10.2340/00015555-1801.
31) In vitro activity of the protegrin IB-367 alone and in combination compared with conventional antifungal agents against dermatophytes., Simonetti O, Silvestri C, Arzeni D, Cirioni O, Kamysz W, Conte I, Staffolani S, Orsetti E, Morciano A, Castelli P, Scalise A, Kamysz E, Offidani AM, Giacometti A, Barchiesi F., Mycoses. 2014 Apr;57(4):233-9. doi: 10.1111/myc.12148.
32) Factitious disorders in adults: two cases of unusual skin ulcers., Giuliodori K, Campanati A, Rosa L, Marconi B, Cellini A, Brandozzi G, Ganzetti G, Simoncini A,Offidani A., Acta Dermatovenerol Alp Pannonica Adriat. 2014 Mar;23(1):13-5.
33) In vitro activity and in vivo animal model efficacy of IB-367 alone and in combination with imipenem and colistin against Gram-negative bacteria., Simonetti O, Cirioni O, Ghiselli R, Orlando F, Silvestri C, Mazzocato S, Kamysz W, Kamysz E, Provinciali M, Giacometti A, Guerrieri M, Offidani A., Peptides. 2014 May;55:17-22. doi: 10.1016/j.peptides.2014.01.029.
34) Response to letter to the editor: 'a precise knowledge of ozonated oils will help to define the favourable and peculiar properties of these functional dermatological matrices'., Campanati A, De Blasio S, Giuliano A, Ganzetti G, Giuliodori K, Pecora T, Consales V, Minnetti I,Offidani A., Burns. 2014 May;40(3):534-5. doi: 10.1016/j.burns.2013.12.013.
35) Efficacy of switching between tumor necrosis factor-alfa inhibitors in psoriasis: results from the Italian Psocare registry., Piaserico S, Cazzaniga S, Chimenti S, Giannetti A, Maccarone M, Picardo M, Peserico A, Naldi L; Psocare Study Group., J Am Acad Dermatol. 2014 Feb;70(2):257-62.e3. doi: 10.1016/j.jaad.2013.10.019.
36) Onabotulinumtoxin type A (Botox(®)) versus Incobotulinumtoxin type A (Xeomin(®)) in the treatment of focal idiopathic palmar hyperhidrosis: results of a comparative double-blind clinical trial., Campanati A, Giuliodori K, Martina E, Giuliano A, Ganzetti G, Offidani A., J Neural Transm. 2014 Jan;121(1):21-6. doi: 10.1007/s00702-013-1074-1.
